Authors: Ahmadzia, H.K. | Lockhart, E.L. | Thomas, S.M. | Welsby, I.J. | Hoffman, M.R. | James, A.H. | Murtha, A.P. | Swamy, G.K. | Grotegut, C.A.
Article Type:
Research Article
Abstract:
INTRODUCTION: Although antifibrinolytic agents are used to prevent and treat hemorrhage, there are concerns about a potential increased risk for peripartum venous thromboembolism. We sought to determine the impact of tranexamic acid and ɛ -aminocaproic acid on in vitro clotting properties in pregnancy. METHODS: Blood samples were obtained from healthy pregnant, obese, and preeclamptic pregnant women (n = 10 in each group) prior to delivery as well as from healthy non-pregnant controls (n = 10). Maximum clot firmness (MCF) and clotting time (CT) were measured using rotation thromboelastometry in the presence of tranexamic acid (3, 30, or 300
…μg/mL) or ɛ -aminocaproic acid (30, 300, or 3000 μg/mL). ANOVA and regression analyses were performed. RESULTS: Mean whole blood MCF was significantly higher in healthy pregnant vs. non-pregnant women (66.5 vs. 57.5 mm, p < 0.001). Among healthy pregnant women, there was no significant difference between mean MCF (whole blood alone, and with increasing tranexamic acid doses = 66.5, 66.1, 66.4, 66.3 mm, respectively; p = 0.25) or mean CT (409, 412, 420, 424 sec; p = 0.30) after addition of tranexamic acid. Similar results were found using ɛ -aminocaproic acid. Preeclamptic women had a higher mean MCF after the addition of ɛ -aminocaproic acid and tranexamic acid (p = 0.05 and p = 0.04, respectively) compared to whole blood alone. CONCLUSIONS: Pregnancy is a hypercoagulable state, as reflected by an increased MCF compared to non-pregnant women. Addition of antifibrinolytic therapy in vitro does not appear to increase MCF or CT for non-pregnant, pregnant, and obese women. Whether antifibrinolytics are safe in preeclampsia may require further study.
Show more
Keywords: Antifibrinolytic therapy, maximum clot firmness, postpartum haemorrhage, thromboelastometry, tranexamic acid
DOI: 10.3233/NPM-16139
Citation: Journal of Neonatal-Perinatal Medicine,
vol. 10, no. 1, pp. 1-7, 2017
Price: EUR 27.50